Antigen-Specific Immune Tolerance Europe Summit 2018
In-Person Event
Dec 10 - 12, 2018
London, England, GB
OVERVIEW
Antigen-Specific Immune Tolerance Europe Summit is organized by Hanson Wade and will be held from Dec 10 - 12, 2018 at Park Plaza Victoria London, London, England, United Kingdom.
Course Description:
The clinical heterogeneity of more than 80 autoimmune diseases presents a significant challenge with respect to the development of therapies designed to re-establish self-tolerance. As the first generation of antigen-specific immune tolerance therapies enters the clinic and excitement around the recent deals, partnerships, IPOs and investments reaching new heights, now is the time for an industry forum for large pharma, pioneering biotech and academia to unite.
Tackling key R&D challenges, such as antigen and, animal model predictability, translation and clinical design, the Antigen-Specific Immune Tolerance Europe Summit is the first European centric, dedicated platform that brings key decision makers together to successfully translate ground breaking science into a novel class of therapies to treat autoimmunity.
Pre-Conference Workshop Day:
• Workshop A:
Monday, 10th December, 2018, 10.00 - 12.30
Translation from Animal to Human Studies: Role of T Regulatory Cells in the Induction/Maintenance of Tolerance
• Workshop B:
Monday, 10th December, 2018, 13.30 - 16.00
Standardization Considerations for Therapeutic Antigen-Specific Tolerogenic Strategies
Speakers:
Robert (Bob) Anderson (ImmusanT), Arpita Maiti (Pfizer), Keith Martin (Apitope), Tim Jessen (Topas Therapeutics), Lawrence Steinman (Tolerion), David Wraith (University of Birmingham), Tim Schmidt (TxCell), José Carballido (Novartis), Mark Peakman (King's College London)
Time:8:00 am - 5:00 pm
Additional details will be posted as soon as they are available.
Course Description:
The clinical heterogeneity of more than 80 autoimmune diseases presents a significant challenge with respect to the development of therapies designed to re-establish self-tolerance. As the first generation of antigen-specific immune tolerance therapies enters the clinic and excitement around the recent deals, partnerships, IPOs and investments reaching new heights, now is the time for an industry forum for large pharma, pioneering biotech and academia to unite.
Tackling key R&D challenges, such as antigen and, animal model predictability, translation and clinical design, the Antigen-Specific Immune Tolerance Europe Summit is the first European centric, dedicated platform that brings key decision makers together to successfully translate ground breaking science into a novel class of therapies to treat autoimmunity.
Pre-Conference Workshop Day:
• Workshop A:
Monday, 10th December, 2018, 10.00 - 12.30
Translation from Animal to Human Studies: Role of T Regulatory Cells in the Induction/Maintenance of Tolerance
• Workshop B:
Monday, 10th December, 2018, 13.30 - 16.00
Standardization Considerations for Therapeutic Antigen-Specific Tolerogenic Strategies
Speakers:
Robert (Bob) Anderson (ImmusanT), Arpita Maiti (Pfizer), Keith Martin (Apitope), Tim Jessen (Topas Therapeutics), Lawrence Steinman (Tolerion), David Wraith (University of Birmingham), Tim Schmidt (TxCell), José Carballido (Novartis), Mark Peakman (King's College London)
Time:8:00 am - 5:00 pm
Additional details will be posted as soon as they are available.
KEY DATES
10 Dec, 2018
Event Start Date
12 Dec, 2018
Event End Date
SPECIALITIES
Pharmacy and MedicineImmunology and MicrobiologySUGGESTED HOTELS
CONFERENCE VENUE
Park Plaza Victoria LondonRELATED CONFERENCES & LIVE WEBINARS
Quick Links